Loading cancer entity…
Loading cancer entity…
Clinical trials
115 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07443137 | CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) | not yet recruiting | Phase 1 | 20 | Stanford UniversityOTHER | 0 | Aug 27, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Aug 27, 2026source: clinicaltrials